MJ Graves Appointed Interim Chief Financial Officer of BioScrip
31 Janvier 2011 - 10:30PM
Business Wire
BioScrip (NASDAQ: BIOS) today announced that Mary Jane “MJ”
Graves, former Chief Financial Officer of Critical Homecare
Solutions, Inc. (“CHS”), which was acquired by BioScrip in 2010,
has been appointed Interim CFO by the Company’s Board of Directors,
effective immediately. David W. Froesel, Jr. has resigned as
Executive Vice President, Chief Financial Officer and
Treasurer.
“We are delighted to have MJ join the BioScrip team as Interim
CFO,” said Richard M. Smith, President and Chief Executive Officer
of BioScrip. “MJ is a seasoned executive with nearly 30 years of
financial and accounting experience. She is extensively familiar
with BioScrip and particularly our home infusion and home health
assets as a result of her tenure at CHS. In addition, as a
consultant, MJ has played an integral role in the execution
strategy developed as a result of our strategic assessment. We look
forward to working with her as we continue to execute our plan for
the future.”
Mr. Froesel advised the Company that his decision was based on
personal reasons. The Company noted that Mr. Froesel indicated that
his decision was not related to any disputes with management, the
Company’s strategic assessment, or issues regarding the integrity
of the Company’s financial statements or accounting policies and
practices.
About MJ Graves
MJ Graves, a Certified Public Accountant, has nearly 30 years of
financial and accounting experience, primarily in the healthcare
sector. As the co-founder and managing director of MCG Resources, a
financial consulting firm serving healthcare providers and private
equity firms, she has been assisting BioScrip with its strategic
assessment and has advised other clients in the development and
execution of their CFO and finance functions, restructuring plans,
financing and operating strategies, and acquisition and divestiture
initiatives. From 2006 until it was sold to BioScrip in 2010, she
served as Chief Financial Officer at Critical Homecare Solutions,
Inc., a start-up home infusion company sponsored by Kohlberg
Partners. Prior to that, she served as Chief Executive Officer and
Chief Financial Officer at Superior Renal Care, Inc., a
multi-facility outpatient dialysis provider. Previously, Ms. Graves
served as President and Chief Operating Officer at StadtSolutions,
LLP, a specialty pharmacy. She held various managerial roles at
specialty pharmacy, Stadtlander Drug Distribution Co, including
Chief Financial Officer and Executive Vice President of
Operations.
About BioScrip
BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a national
provider of specialty pharmacy and home care products and services
that partners with patients, physicians, hospitals, healthcare
payors and pharmaceutical manufacturers to provide clinical
management solutions and delivery of cost-effective access to
prescription medications. Our services are designed to improve
clinical outcomes for chronic and acute healthcare conditions while
controlling overall healthcare costs.
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024